Massachusetts Financial Services
OMED

Massachusetts Financial Services’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Massachusetts Financial Services’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-15,358
Closed -$396K – 952
2015
Q1 		$396K Buy
+15,358
New +$390K ﹤0.01% 849

Other funds holding OMED

ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Apex Capital Orinda, California $938M AUM 4.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Massachusetts Financial Services's OMED Position: Q2 2015 in Review

Massachusetts Financial Services sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q2 2015, closing a stake of 15,358 shares — an estimated $396K sold.

Massachusetts Financial Services first reported a position in OMED in Q1 2015 and held it in 1 quarter. The position peaked at $396K in Q1 2015. 83 funds tracked by Wall St. Rank hold OMED as of Q2 2015.

  • Massachusetts Financial Services reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • Massachusetts Financial Services sold 15,358 OncoMed Pharmaceuticals, Inc. shares in Q2 2015, an estimated $396K.
  • Massachusetts Financial Services first reported a position in OncoMed Pharmaceuticals, Inc. in Q1 2015 and held it in 1 quarter.
  • Massachusetts Financial Services's OncoMed Pharmaceuticals, Inc. position peaked at $396K in Q1 2015.
  • 83 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q2 2015.

Based on Massachusetts Financial Services's 13F filing for Q2 2015, filed 13 Aug 2015.